Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-001594
Filing Date
2025-01-16
Accepted
2025-01-16 19:49:49
Documents
2
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 form3-01172025_120145.html 3  
1 form3-01172025_120145.xml 3 1656
2 ex24-01172025_120145.htm EX-24 4833
  Complete submission text file 0001415889-25-001594.txt   8244
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHINOOK THERAPEUTICS U.S., INC. 1600 FAIRVIEW AVE. E. SEATTLE WA 98102
Business Address
Glicklich Alan (Reporting) CIK: 0001823197 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39538 | Film No.: 25536768